Antibiotic Stewardship

Antibiotic Stewardship

Participants

  • Hilari French

  • Eoin Ryan

  • Sarah Humphreys

Learning Objectives

  1. Gain perspective on the global importance of antimicrobial resistance

    • Key Question: "Why do we care?"

  2. Understand regulations governing antibiotic use in food-producing animals in the US

    • Key Question: "What’s our role as vets when it comes to antibiotics?"

  3. Describe the 5 key elements to implementing antibiotic stewardship in food-producing animals

    • Key Question: "How can we do our jobs well?"

Overview

  • Antimicrobial Resistance

  • Veterinary Feed Directive

  • Coming Regulations

  • Antibiotic Stewardship

Antimicrobial Resistance (AMR) Overview

  • Definition: When an infectious agent changes in response to therapeutic pressures in the environment.

  • Intrinsic AMR Example: Mycoplasma spp. lacks a cell wall, making it resistant to antibiotics that target cell walls.

  • Induced AMR Example: Bacteria can possess DNA that is not normally expressed until exposed to stressors such as antibiotics.

Mechanisms of Antibiotic Resistance Spread

  • Animals receive antibiotics, leading to the development of resistant bacteria in their gut.

  • Drug-resistant bacteria can persist on meat from these animals.

  • If not handled or cooked properly, these bacteria can spread to humans.

  • Fertilizers or water containing feces from treated animals may contaminate food crops.

  • In humans:

    • Example: George receives antibiotics, develops resistant bacteria, and spreads these in the community.

    • Healthcare facilities serve as vectors for resistant bacteria spread through unclean hands of providers.

Statistics on AMR in Humans

  • About 2 million infections yearly.

  • Approximately 23,000 deaths annually.

  • Contributes to a $20 billion direct cost and a $35 billion indirect cost burden in healthcare.

  • 50% of all antimicrobial prescriptions in humans are deemed unnecessary, a result of overuse of antimicrobials.

Impact of AMR

  • Potential deaths from AMR projected to reach 10 million by 2050.

  • Growing threats from antimicrobial resistance could surpass cancer deaths.

  • Recent media highlights include fast-food chains taking action against antibiotic use in livestock.

Characteristics of AMR

  • What is AMR?

    • The ability of microorganisms (like bacteria and some viruses) to survive and grow in the presence of an antimicrobial that should effectively eliminate them.

    • Leads to ineffective standard treatments and persistent infections.

    • Bacteria can become multi-resistant, and some infections may become untreatable.

Selection Pressure and Resistance

  • AMR is partially driven by natural phenomena where selective pressure from antibiotics favors resistant strains.

  • The excessive use of antibiotics creates additional selection pressure that exacerbates resistance development.

  • Bacteria can share resistance genes via plasmids, further complicating control efforts.

Multiresistant Bacteria Analysis

  • List includes resistance levels for various antibiotics, with some bacteria exhibiting resistance to multiple antibiotic classes, e.g.:

    • Amoxicillin: RESISTANT

    • Co-amoxiclav: RESISTANT

    • Cefuroxime: RESISTANT

    • Meropenem: RESISTANT

    • Colistin: NON RESISTANT

Sources of AMR Problem

  • Contamination vectors in hospitals, clinics, and via food supply.

  • Waste disposal issues and environmental contamination contribute to AMR dissemination.

One Health Concept

  • Integrated approach linking human health, animal health, and environmental health is crucial in addressing AMR.

  • Over 60% of human infectious diseases are zoonoses originating from animals.

  • Resistance genes can cycle between humans, animals, and the environment.

Global Health Threats

  • AMR ranked among top health threats globally in reports by WHO.

  • Recent data indicates significant deaths linked to bacterial AMR, with E. coli, Staph aureus, and others being leading pathogens.

Factors Contributing to Increased AMR Risk

  1. Inappropriate Use: Overuse and incorrect disposal of antibiotics increase selective pressure.

  2. Inaccurate Prescribing: Utilizing last-line antibiotics as first-line therapy and non-completion of treatment courses exacerbate resistance.

Antibiotic Use in Food Animals

  • In the US, 64% of antibiotics sold are for food animals.

    • Use categories defined by WHO: therapeutic, disease prevention, and growth promotion.

  • The FDA has moved towards phasing out non-therapeutic antibiotics for growth promotion in livestock.

Veterinary Feed Directive (VFD)

Regulatory Changes
VFD Guidance for Industry 209
  • Aimed at ensuring judicious antimicrobial use by limiting medically important drugs to necessary uses and requiring veterinary oversight.

VFD Guidance for Industry 213
  • Phasing out non-therapeutic use of medically important antimicrobials for feed efficiency and weight gain.

  • All use must involve veterinary input.

Implications of VFD

  • All in-feed uses of important antimicrobials require valid veterinary-client-patient relationships (VCPR).

  • Drastic changes are anticipated with numerous drug transitions from over-the-counter to prescription statuses affecting production indicating animals.

Recent Legislative Developments

  • California, Maryland, and Oregon legislation focuses on stricter antimicrobial use guidelines in livestock and enhances reporting requirements on antibiotic use in food animals.

Antibiotic Stewardship Goals for Food Animal Vets

  • Reduce animal pain and suffering.

  • Protect livestock producers' livelihoods.

  • Ensure safety in food production.

  • Minimize resistance in pathogens.

Key Elements of Antibiotic Stewardship

  1. Focus on Disease Prevention

    • Importance of herd health, vaccinations, deworming, and good nutrition.

  2. Efficient Diagnosis of Disease

    • Prioritize quick and accurate diagnostics for better treatment decisions.

  3. Selection of Appropriate Antibiotics

    • Consider specific bacteria, the infection site, disease nature, and in vitro susceptibility.

  4. Record Keeping

    • Maintain detailed records of treatments, including animal IDs, drugs administered, and withdrawal times.

  5. Veterinary Client Patient Relationship (VCPR)

    • Strengthen relationships between vet and producers, ensure knowledge of management practices, and facilitate timely follow-up.

    • Develop written treatment protocols for common diseases to improve response and accountability.

Conclusion

  • Emphasize the necessity for careful antibiotic use to ensure effective treatments in both human and veterinary medicine and reduce the risk of increasing AMR.

  • Quote highlight: "It’s not about using less antibiotics. It’s about using the right antibiotic for the right diagnosis and for the right duration of time." – Susan Bleasdale, MD.